Lower THBS2 expression was linked to advanced disease status and slower tumour regression after preoperative neoadjuvant concurrent chemoradiotherapy, THBS2 acted as an independent negative prognostic factor in rectal cancer.51 This evidence concerns the gene THBS2 and neoplasm.